FEMY

Healthcare Medical Instruments & Supplies

Femasys Inc.

$2.11

+0.06 +2.68% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 1:51 PM ET	2.11

Key Stats

Market Cap

17.63M

Avg Volume

717,239

EPS

-$3.28

52W High

$22.20

52W Low

$1.96

Div. Yield

0.0%

Analyst Ratings

Strong Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-0.99

P/B Ratio

1.58

P/S Ratio

7.67

EV/EBITDA

-1.19

EV/Revenue

8.92

Margins

Gross Margin 60.9%

Operating Margin (1526.7%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(18.9%)

Return on Equity

(425.0%)

Return on Assets

(84.2%)

Liquidity & Leverage

Current Ratio

2.14

Quick Ratio

0.41

Debt / Equity

1.19

Total Cash

1.44M

Total Debt

4.79M

About

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

femasys.com